Improving Tissue Repair After Injury in the Muscle-tendon Interface Muscle Tissue Injury
Condition:   Muscle Injury Interventions:   Other: Electrical stimulation;   Other: Growth hormone (somatropin);   Other: Control (No electrical stimulation, nor growth hormone) Sponsor:   Bispebjerg Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2023 Category: Research Source Type: clinical trials

Improving Tissue Repair After Injury in the Muscle-tendon Interface Muscle Tissue Injury
Condition:   Muscle Injury Interventions:   Procedure: Electrical stimulation;   Drug: Growth hormone (somatropin);   Other: Control (No electrical stimulation, nor growth hormone) Sponsor:   Bispebjerg Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2023 Category: Research Source Type: clinical trials

Improving Tissue Repair After Injury in the Muscle-tendon Interface Muscle Tissue Injury
Condition:   Muscle Injury Interventions:   Other: Electrical stimulation;   Other: Growth hormone (somatropin);   Other: Control (No electrical stimulation, nor growth hormone) Sponsor:   Bispebjerg Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2023 Category: Research Source Type: clinical trials

A Trial to Investigate Different Doses of Lonapegsomatropin Compared to Somatropin in Individuals With Turner Syndrome
Condition:   Turner Syndrome Interventions:   Biological: Lonapegsomatropin;   Drug: Somatropin Sponsor:   Ascendis Pharma Endocrinology Division A/S Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 19, 2023 Category: Research Source Type: clinical trials

A Multicenter, Phase 2, Randomized, Open-label, Active-controlled, Parallel Group Clinical Trial to Investigate the Safety, Tolerability, and Efficacy of Different Dose Levels of Once-weekly Lonapegsomatropin Compared to Daily Somatropin in Prepubertal Individuals With Turner Syndrome
Condition:   Turner Syndrome Interventions:   Biological: Lonapegsomatropin;   Device: Somatropin Sponsor:   Ascendis Pharma Endocrinology Division A/S Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 19, 2023 Category: Research Source Type: clinical trials